REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07222761 updates: 1. completion date: 2034-09-17 → 2034-08-23 2. primary completion date: 2029-06-15 → 2029-05-21
Clinical trial NCT07222761 updates: 1. completion date: 2034-09-17 → 2034-08-23 2. primary completion date: 2029-06-15 → 2029-05-21
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical